Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For RRX
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
33%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 2.52 2.62 2.55
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 5.91 21.67 20.46
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -1.56 94.19 95.69
Cash -19.06 7.01 8.66
Capex 39.24 -0.28 -0.46
Free Cash Flow -62.26 0.97 2.58
Revenue -3.91 23.31 24.26
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 2.05 0.36 0.35
Operating Margin -1.16 0.09 0.10
ROA -63.74 < 0.005 < 0.005
ROE -64.07 < 0.005 < 0.005
ROIC -17.45 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of RRX is permitted for members.
5 Growth
The "Growth Entry" for the Focus of RRX is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of RRX is permitted for members.